ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Apr 22, 2016
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Exercise/Conversion
Common Stock
2016-04-21$5.01/sh+15,000$75,150→ 341,963 total - Exercise/Conversion
Stock Option (right to buy)
2016-04-21−15,000→ 0 totalExercise: $5.01From: 2006-04-26Exp: 2016-04-26→ Common Stock (15,000 underlying)